Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia

Sai-Juan Chen, Guang-Biao Zhou, Xiao-Wei Zhang, Jian-Hua Mao, Hugues de Thé, Zhu Chen

Blood (2011) 117 (24): 6425–6437.

https://doi.org/10.1182/blood-2010-11-283598

Published: 2011

Journal Articles

Front-Line Therapy with Arsenic Trioxide/All- Trans -Retinoic Acid Combination and Chemotherapy Improves Cure Rates in Newly Diagnosed Patients with Acute Promyelocytic Leukemia

Jiong Hu, MD, Yuan-fang Liu, Chuan-feng Wu, Guang-biao Zhou, Zhi-Xiang Shen, Jun-min Li, Zhen-Yi Wang, Sai-Juan Chen, Zhu Chen

Blood (2008) 112 (11): 2970.

https://doi.org/10.1182/blood.V112.11.2970.2970

Published: 2008

Journal Articles

Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo

Guang-Biao Zhou, Hui Kang, Lan Wang, Li Gao, Ping Liu, Jun Xie, Feng-Xiang Zhang, Xiang-Qin Weng, Zhi-Xiang Shen, Jue Chen, Long-Jun Gu, Ming Yan, Dong-Er Zhang, Sai-Juan Chen, Zhen-Yi Wang, Zhu Chen

Blood (2006) 109 (8): 3441–3450.

https://doi.org/10.1182/blood-2006-06-032250

Published: 2006

Includes: Supplemental data

Journal Articles

Bortezomib Combined with Harringtonine or Arsenious Acid Induced Apoptosis in HL-60 Cells and Its Mechanism.

Fan Yi Meng, MD, Yun-bi Fu, MD, Qi-xin Sun, MD, Jun Xie, MD, Guang-biao Zhou, MD

Blood (2006) 108 (11): 4412.

https://doi.org/10.1182/blood.V108.11.4412.4412

Published: 2006

Journal Articles

High Frequency Gain-of-Function Mutation and/or Over-Expression of Proto-Oncogene C-KIT as Major Contributor to the Leukemogenesis in Human Acute Myeloid Leukemia with t(8; 21).

Guang-Biao Zhou, Yue-Ying Wang, Tong Yin, Xue-Tao Bai, Wen-Xue Liang, Feng Xu, Yi-Wei Liu, Zhu Chen, Sai-Juan Chen

Blood (2004) 104 (11): 4322.

https://doi.org/10.1182/blood.V104.11.4322.4322

Published: 2004

NARROW

From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia

Front-Line Therapy with Arsenic Trioxide/All- Trans -Retinoic Acid Combination and Chemotherapy Improves Cure Rates in Newly Diagnosed Patients with Acute Promyelocytic Leukemia

Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo

Bortezomib Combined with Harringtonine or Arsenious Acid Induced Apoptosis in HL-60 Cells and Its Mechanism.

High Frequency Gain-of-Function Mutation and/or Over-Expression of Proto-Oncogene C-KIT as Major Contributor to the Leukemogenesis in Human Acute Myeloid Leukemia with t(8; 21).

Email alerts

ASH Publications

American Society of Hematology

From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia

Front-Line Therapy with Arsenic Trioxide/All- Trans -Retinoic Acid Combination and Chemotherapy Improves Cure Rates in Newly Diagnosed Patients with Acute Promyelocytic Leukemia

Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo

Bortezomib Combined with Harringtonine or Arsenious Acid Induced Apoptosis in HL-60 Cells and Its Mechanism.

High Frequency Gain-of-Function Mutation and/or Over-Expression of Proto-Oncogene C-KIT as Major Contributor to the Leukemogenesis in Human Acute Myeloid Leukemia with t(8; 21).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only